GSK makes strong start to 2025 with growth in sales, profits and earnings
Q1 2025 £m % AER % CER Turnover 7,516 2 4 Total operating profit 2,216 49 50 Total operating margin % 29.5% 9.2ppts 9.0ppts Total EPS 39.7p 55 56 Core…
New hope in the fight against Hepatitis C: Broadly effective innovative vaccine design
Globally, approximately 58 million people are chronically infected with HCV, resulting in 290,000 annual deaths due to complications such as liver cirrhosis and liver cancer. Although modern antiviral treatments achieve…